Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Jinsu Pharmaceutical is a specialized pharmaceutical manufacturer based in Foshan, China, focusing on the production of anti-infective drugs. The company is a significant producer of carbapenem antibiotics, such as meropenem and imipenem/cilastatin, as well as a wide range of cephalosporin sterile powders for injection. Jinsu Pharmaceutical operates large-scale, GMP-compliant manufacturing facilities and supplies critical care medications to hospitals across China and international markets. Their business model centers on high-quality generic production and the development of advanced formulations for severe infectious diseases. The company has established a strong presence in the domestic Chinese market through its focus on essential medicines and hospital-grade antibiotics. In addition to manufacturing, they engage in the research and development of new drug delivery systems for anti-infective therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Jinsu Pharmaceutical.